The Mycobacterium smegmatis bd -II terminal oxidase employs a carboxylate shift mechanism
Proceedings of the National Academy of Sciences · 17.03.2026 · 123 (11)
DOI: 10.1073/pnas.2515348123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 10.03.2026. Verfasst von Terezia Kovalova und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, Stockholm University, Stockholm 116 91, Sweden. Hauptthemen laut MEDLINE: Mycobacterium smegmatis, Oxidoreductases, Bacterial Proteins, Cytochrome b Group. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Knut och Alice Wallenbergs Stiftelse (kawforskning), Vetenskapsrådet (VR).
Abstract (Originalsprache)
Cytochrome bd is a terminal oxidase expressed under low oxygen conditions and central for the survival of many pathogens. Here, we characterize the cyt bd -II from Mycobacterium smegmatis , a member of a hitherto uncharacterized evolutionary group (qOR-2) of bd oxidases, by combining biochemical studies with cryo-electron microscopy (cryo-EM), and multiscale simulations. Overexpressing the appCB operon in its native host led to production of a highly active bd -II ( k obs = 30 e − s −1 ) that together with a high-resolution (2.8 Å) cryo-EM structure and multiscale simulations reveal unique proton pathways and oxygen channels responsible for its function. We propose that a pH-dependent molecular switch, involving coordination changes of heme d and surrounding bulky residues regulate substrate access into the active site. Taken together, our findings provide detailed mechanistic insight of qOR-2 type bd oxidases, and a basis for understanding the evolution of the superfamily.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Biophysics, Stockholm University, Stockholm 116 91, Sweden.
ORCID-Profile: Terezia Kovalova, Mateusz Janczak, Ana P Gamiz-Hernandez, Daniel Lundin, Ville R I Kaila, Martin Högbom, Pia Ädelroth
Förderung
- Knut och Alice Wallenbergs Stiftelse (kawforskning)
- Vetenskapsrådet (VR)
Zitieren
APA
Kovalova, T., Janczak, M., Gamiz-Hernandez, A. P., Lundin, D., Sharma, S., Vilhjálmsdóttir, J., Sjöstrand, D., Kaila, V. R. I., Högbom, M., & Ädelroth, P. (2026). The Mycobacterium smegmatis bd -II terminal oxidase employs a carboxylate shift mechanism. Proceedings of the National Academy of Sciences, 123(11). https://doi.org/10.1073/pnas.2515348123
Vancouver
Kovalova T, Janczak M, Gamiz-Hernandez AP, Lundin D, Sharma S, Vilhjálmsdóttir J, et al. The Mycobacterium smegmatis bd -II terminal oxidase employs a carboxylate shift mechanism. Proceedings of the National Academy of Sciences. 2026;123(11). doi:10.1073/pnas.2515348123
BibTeX
@article{Kovalova2026,
author = {Kovalova, Terezia and Janczak, Mateusz and Gamiz-Hernandez, Ana P and Lundin, Daniel and Sharma, Soni and Vilhjálmsdóttir, Johanna and Sjöstrand, Dan and Kaila, Ville R I and Högbom, Martin and Ädelroth, Pia},
title = {The Mycobacterium smegmatis bd -II terminal oxidase employs a carboxylate shift mechanism},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {11},
doi = {10.1073/pnas.2515348123}
}
EUVIMED